Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer clinical trial (NCT01688492). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this combination treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer clinical trial (NCT01688492). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of these treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer clinical trial (NCT01688492). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer clinical trial (NCT01688492). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the expected duration of my participation in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer clinical trial (NCT01688492). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer clinical trial (NCT01688492). Contact the study team or your healthcare provider for specific answers.

What this study is about